These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2425957)
1. Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells. Kaysen J; Spriggs D; Kufe D Cancer Res; 1986 Sep; 46(9):4534-8. PubMed ID: 2425957 [TBL] [Abstract][Full Text] [Related]
2. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma. Boothman DA; Briggle TV; Greer S Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263 [TBL] [Abstract][Full Text] [Related]
3. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755. Boothman DA; Briggle TV; Greer S Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761 [TBL] [Abstract][Full Text] [Related]
4. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies. Mekras JA; Boothman DA; Perez LM; Greer S Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164 [TBL] [Abstract][Full Text] [Related]
5. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU). Beumer JH; Parise RA; Newman EM; Doroshow JH; Synold TW; Lenz HJ; Egorin MJ Cancer Chemother Pharmacol; 2008 Jul; 62(2):363-8. PubMed ID: 17899082 [TBL] [Abstract][Full Text] [Related]
6. 5-Fluorouracil incorporation in DNA of human breast carcinoma cells. Major PP; Egan E; Herrick D; Kufe DW Cancer Res; 1982 Aug; 42(8):3005-9. PubMed ID: 6212116 [TBL] [Abstract][Full Text] [Related]
7. Effect of methotrexate on incorporation and excision of 5-fluorouracil residues in human breast carcinoma DNA. Herrick DJ; Major PP; Kufe DW Cancer Res; 1982 Dec; 42(12):5015-7. PubMed ID: 7139606 [TBL] [Abstract][Full Text] [Related]
8. The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome. Vandamme B; Liebaers I; Hens L; Bernheim JL; Roobol C Hum Genet; 1988 Aug; 79(4):341-6. PubMed ID: 2970425 [TBL] [Abstract][Full Text] [Related]
9. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies. Mekras JA; Boothman DA; Greer SB Cancer Res; 1985 Nov; 45(11 Pt 1):5270-80. PubMed ID: 2932216 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and mechanism of action of 5-fluorodeoxycytidine. Newman EM; Santi DV Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6419-23. PubMed ID: 6959127 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice. Beumer JH; Eiseman JL; Parise RA; Joseph E; Holleran JL; Covey JM; Egorin MJ Clin Cancer Res; 2006 Dec; 12(24):7483-91. PubMed ID: 17138702 [TBL] [Abstract][Full Text] [Related]
13. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cory JG; Breland JC; Carter GL Cancer Res; 1979 Dec; 39(12):4905-13. PubMed ID: 498116 [TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS assay for the quantitation of FdCyd and its metabolites FdUrd and FU in human plasma. Holleran JL; Eiseman JL; Parise RA; Kummar S; Beumer JH J Pharm Biomed Anal; 2016 Sep; 129():359-366. PubMed ID: 27454087 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model. van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304 [TBL] [Abstract][Full Text] [Related]
16. Reversal of deamination-related cytotoxicity of 5-methyl-2'-deoxycytidine by tetrahydrouridine in human leukemia cells. Jekunen A; Vilpo JA J Natl Cancer Inst; 1984 Nov; 73(5):1087-91. PubMed ID: 6593484 [TBL] [Abstract][Full Text] [Related]
17. Oral and intravenous pharmacokinetics of 5-fluoro-2'-deoxycytidine and THU in cynomolgus monkeys and humans. Holleran JL; Beumer JH; McCormick DL; Johnson WD; Newman EM; Doroshow JH; Kummar S; Covey JM; Davis M; Eiseman JL Cancer Chemother Pharmacol; 2015 Oct; 76(4):803-11. PubMed ID: 26321472 [TBL] [Abstract][Full Text] [Related]
18. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system. Sawyer RC; Stolfi RL; Martin DS Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227 [TBL] [Abstract][Full Text] [Related]
19. Stability of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in combination. Guo D; Myrdal PB; Karlage KL; O'Connell SP; Wissinger TJ; Tabibi SE; Yalkowsky SH AAPS PharmSciTech; 2010 Mar; 11(1):247-52. PubMed ID: 20151336 [TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo. Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]